Speech-Language Pathologists in Gretna, LA Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Ms. Lauren Ann Duhon, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 605 Lapalco Blvd, Gretna, LA 70056 Phone: 504-371-9355

Kara Rae Alexander, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3201 Wall Blvd, Gretna, LA 70056 Phone: 318-471-3616

Mrs. Laura Early Loupe, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2052 S Glencove Ln, Gretna, LA 70056 Phone: 504-234-1206

Althea Brown Robinson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1025 Lake Frances Dr, Gretna, LA 70056 Phone: 504-453-6622

Alisyn Mundy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 816 Franklin Ave, Gretna, LA 70053 Phone: 318-623-4647

News Archive

Hemophilia B patients produce near-normal levels of clotting factor IX after gene therapy, study shows

Researchers are reporting the highest and most sustained levels to date of the essential blood-clotting factor IX in patients with the inherited bleeding disorder hemophilia B.

Scientists gain greater understanding of how embryos differentiate left from right

Researchers at the Forsyth Institute have discovered a new mechanism responsible for early left/right patterning, the process by which organs locate themselves on the left or right side of the body.

Afghanistan, African countries lead global food insecurity list

Afghanistan and nine African countries top a list measuring global food insecurity, which was released on Thursday, Agence France-Presse reports.

High zinc status in lung cells slows growth and induces DNA

Researchers at the University of Maryland at College Park have discovered that Normal Human Bronchial Epithelial (NHBE) cells cultured in medium with elevated zinc level, at the high end of plasma zinc attainable by oral supplementation, demonstrated inhibition of cell growth, up-regulation of growth arrest and DNA damage-induced gene (Gadd45) mRNA and protein expression, and blockage of G2/M cell cycle progression.

Strathspey Crown Holdings announces acquisition of Novus Via assets

Strathspey Crown Holdings LLC announced today the acquisition of the portfolio companies of Novus Via LP, a Nevada-based venture capital investment firm focused on end-stage development and commercialization of advanced electromagnetic and electrochemical technologies spanning healthcare, clean energy and coherent acoustics. The terms of the transaction were not disclosed.

Read more Medical News

› Verified 7 days ago